Diabetes Care · 2014 · 122 citations · 19 references
MedicineEndocrinologyPediatricsDiabetologyPediatric EndocrinologyPediatric TherapeuticsBlood Glucose MonitoringContinuous Glucose MonitoringDiabetes ControlDiabetes MellitusGlycemic ControlGlycemic MonitoringAlgorithm Performance EvaluationClosed-loop Insulin TherapyDiabetes Management In ChildrenGlucose Monitoring DevicesPediatric Diabetes Self-managementPediatric Glucose MonitoringPoint-of-care Glucose MeasurementType 1 Diabetes Monitoring
OBJECTIVE: To determine the safety and efficacy of an automated unified safety system (USS) in providing overnight closed-loop (OCL) control in children and adolescents with type 1 diabetes attending diabetes summer camps. RESEARCH DESIGN AND METHODS: The Diabetes Assistant (DIAS) USS used the Dexcom G4 Platinum glucose sensor (Dexcom) and t:slim insulin pump (Tandem Diabetes Care). An initial inpatient study was completed for 12 participants to evaluate safety. For the main camp study, 20 participants with type 1 diabetes were randomized to either OCL or sensor-augmented therapy (control conditions) per night over the course of a 5- to 6-day diabetes camp. RESULTS: Subjects completed 54 OCL nights and 52 control nights. On an intention-to-treat basis, with glucose data analyzed regardless of system status, the median percent time in range, from 70-150 mg/dL, was 62% (29, 87) for OCL nights versus 55% (25, 80) for sensor-augmented pump therapy (P = 0.233). A per-protocol analysis allowed for assessment of algorithm performance. The median percent time in range, from 70-150 mg/dL, was 73% (50, 89) for OCL nights (n = 41) versus 52% (24, 83) for control conditions (n = 39) (P = 0.037). There was less time spent in the hypoglycemic range <50, <60, and <70 mg/dL during OCL compared with the control period (P = 0.019, P = 0.009, and P = 0.023, respectively). CONCLUSIONS: The DIAS USS algorithm is effective in improving time spent in range as well as reducing nocturnal hypoglycemia during the overnight period in children and adolescents with type 1 diabetes in a diabetes camp setting.
19
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Moshe Phillip, Tadej Battelino, Eran Atlas et al. · New England Journal of Medicine · 2013 · 433 citations · Full text
Fully Integrated Artificial Pancreas in Type 1 Diabetes
Marc D. Breton, Anne Farret, Daniela Bruttomesso et al. · Diabetes · 2012 · 311 citations · Full text